Customize your JAMA Network experience by selecting one or more topics from the list below.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Adhikari S, Pantaleo NP, Feldman JM, Ogedegbe O, Thorpe L, Troxel AB. Assessment of Community-Level Disparities in Coronavirus Disease 2019 (COVID-19) Infections and Deaths in Large US Metropolitan Areas. JAMA Netw Open. 2020;3(7):e2016938. doi:10.1001/jamanetworkopen.2020.16938
Urban counties in large metropolitan areas in the United States are among the most affected by the coronavirus disease 2019 (COVID-19) pandemic, with high proportions of confirmed infection among those who have been tested.1 While there is growing evidence of disparities by race/ethnicity across neighborhoods,2,3 the extent to which neighborhood poverty is associated with infection and deaths is not clear. In this cross-sectional study, we examined the association of neighborhood race/ethnicity and poverty with COVID-19 infections and related deaths in urban US counties, hypothesizing disproportionate burdens in counties with a larger percentage of the population belonging to minority racial/ethnic groups and a higher rate of poverty. This study is among the first to investigate such associations in US metropolitan areas.
Counties were grouped by US Office of Management and Budget–defined combined statistical areas (CSAs).4 We included CSAs centered on the following 10 major US cities, all of which experienced early surges of COVID-19 infections: New York, New York; Boston, Massachusetts; New Orleans, Louisiana; Detroit, Michigan; Los Angeles, California; Atlanta, Georgia; Miami, Florida; Chicago, Illinois; Philadelphia, Pennsylvania; and Seattle, Washington. Combined, these CSAs accounted for 63.5% of confirmed COVID-19 infections (834 126 of 1 312 679) in the United States as of May 10, 2020. We included 158 counties that experienced at least 1 death attributed to confirmed COVID-19.
Information regarding county-level poverty rates and median household income was obtained from the 2018 US Census Small Area Income and Poverty Estimates Program.5 We calculated county proportions of racial/ethnic minority groups (per US Census methodology, individuals who did not identify as non-Hispanic White alone) using the 2018 US Census Annual Estimates of the Resident Population.5 We also obtained cumulative COVID-19 infection and death data, made publicly available by the Centers for Disease Control and Prevention as well as state health departments and aggregated by USA Facts6 on May 11, 2020. Per the Common Rule, institutional review board approval was unnecessary because of the use of publicly available, deidentified data. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for cross-sectional studies.
Cumulative COVID-19 incident infections and deaths were linked with population-level and community-level variables by unique county federal information processing standards codes. We calculated cumulative incidence, ie, the total number of COVID-19 infections and deaths per 100 000 individuals (hereafter, infection and death rates) using the population of each county as the denominator. Quartiles for percentage of residents from racial and ethnic minority groups were calculated for the 158 counties, ranging from substantially White (3.0%-17.9%) to less diverse (18.0%-29.4%), more diverse (29.5%-44.5%), and substantially non-White (>44.5%). The percentage of individuals living below the poverty level was binarized at the median poverty rate of the data set (ie, 10.7%) into less-poverty counties and more-poverty counties.
We summarized county-level characteristics for each CSA. To model the association between community factors and COVID-19 infection and death rates, we fitted random-effect linear regression models on the logarithm of infection and death rates with CSA-level random intercepts to account for clustering of counties within CSAs and including coefficients for poverty and race/ethnicity categories as well as their interactions. We compared model-adjusted rates for each race/ethnicity category among less-poverty counties and more-poverty counties. Statistical software R version 3.6.3 (R Project for Statistical Computing) package lme4 was used for the analyses. All statistical tests were 2-tailed, with a significance threshold of P < .05.
Table 1 summarizes the counties within the CSAs. Of 158 counties, 81 (51.3%) were considered less-poverty counties and 77 (48.7%), more-poverty counties. For the less-poverty counties, the median county-level income was $79 834 (range, $53 060-$119 731) compared with $60 240 (range, $36 850-$88 960) for the more-poverty counties. Infection rates for COVID-19 ranged from 41.7 to 3821.8 per 100 000 individuals, and death rates ranged from 0.34 to 271.3 per 100 000 individuals.
Model-adjusted rates and rate ratios (RRs) are reported in Table 2. In more-poverty counties, those with substantially non-White populations had an infection rate nearly 8 times that of counties with substantially White populations (RR, 7.8; 95% CI, 5.1-12.0) and a death rate more than 9 times greater (RR, 9.3; 95% CI, 4.7-18.4). Indeed, we found that among both more-poverty and less-poverty counties, those with substantially non-White or more diverse populations had higher expected cumulative COVID-19 incident infections compared with counties with substantially White or less-diverse populations (eg, more diverse counties with less poverty: RR, 3.2; 95% CI, 2.3-4.6). Similar associations were observed for deaths (eg, more diverse counties with less poverty: RR, 3.8; 95% CI, 2.2-6.7).
While the excess burden of both infections and deaths was experienced by poorer and more diverse areas, racial and ethnic disparities in COVID-19 infections and deaths existed beyond those explained by differences in income. Lack of access to disaggregated data precludes us from further exploring causal mechanisms, such as structural racism or other social drivers. Studies that leverage community information with individual-level health data are likely to provide additional insights.
Accepted for Publication: July 1, 2020.
Published: July 28, 2020. doi:10.1001/jamanetworkopen.2020.16938
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Adhikari S et al. JAMA Network Open.
Corresponding Author: Samrachana Adhikari, PhD, Department of Population Health, New York University Grossman School of Medicine, 180 Madison Ave, 4th Floor, Ste 454, New York, NY 10016 (firstname.lastname@example.org).
Author Contributions: Dr Adhikari and Mr Pantaleo had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Dr Adhikari and Mr Pantaleo contributed equally.
Concept and design: Adhikari, Pantaleo, Feldman, Ogedegbe, Thorpe.
Acquisition, analysis, or interpretation of data: Adhikari, Pantaleo, Troxel.
Drafting of the manuscript: Adhikari, Pantaleo, Ogedegbe.
Critical revision of the manuscript for important intellectual content: Adhikari, Pantaleo, Feldman, Thorpe, Troxel.
Statistical analysis: Adhikari, Pantaleo, Troxel.
Obtained funding: Adhikari.
Administrative, technical, or material support: Feldman, Thorpe.
Conflict of Interest Disclosures: None reported.
Funding/Support: This work was supported by funding from Johnson & Johnson and by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under award number U54MD000538 to Dr Adhikari.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: Dr Ogedegbe is an associate editor of JAMA Network Open, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance. The content is solely the responsibility of the authors and does not necessarily represent the official views of Johnson & Johnson or the National Institutes of Health.
Create a personal account or sign in to: